Testing effectiveness (Phase 2)Study completedNCT00281632
What this trial is testing
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
Who this might be right for
Peritoneal CancerOvarian CancerNeoplasms, Ovarian+1 more
GlaxoSmithKline 35